肝硬化患者经肝脏/脾脏硬度分层筛查后的静脉曲张出血风险低
本研究为一项非劣效、开放标签、随机对照试验(NCT02024347)的前瞻性随访研究,纳入548例已知慢性肝病、影像学证实肝硬化且肝功能代偿的成人患者,随机分为肝脏/脾脏硬度测量(LSSM)引导筛查组(n=274)和常规内镜筛查组(n=274)。在41.3±12.6个月随访期间,LSSM组12/274例(4.4%)和常规组11/274例(4.0%)发生静脉曲张出血(log-rank检验P=0.724),两组肝脏事件发生率也相似(P=0.327)。结论认为,接受LSSM引导筛查的肝硬化患者未来静脉曲张出血风险同样较低,肝硬化患者可首先进行LSSM测量以节省多达一半的上消化道内镜检查。
要点
- LSSM组静脉曲张出血12/274例(4.4%),常规组11/274例(4.0%),log-rank检验P=0.724。
- 两组肝脏事件发生率相似(P=0.327)。
- 肝硬化患者可首先进行LSSM测量以节省多达一半的上消化道内镜检查。
核心结论
- 接受LSSM引导静脉曲张筛查的肝硬化患者未来发生静脉曲张出血的风险同样较低。
- 肝硬化患者可首先进行LSSM测量以节省多达一半的上消化道内镜检查。
研究设计与样本
- 非劣效、开放标签、随机对照试验(NCT02024347)的前瞻性随访研究。
- 纳入548例已知慢性肝病、影像学证实肝硬化且肝功能代偿的成人患者,随机分为LSSM组(n=274)和常规组(n=274)。
主要发现
- 患者以中年男性为主(平均年龄59岁,男性68.9%),85%为病毒性肝炎相关肝硬化。
- LSSM组127例(46.4%)和常规组263例(96.0%)患者接受了上消化道内镜检查。
- 随访41.3±12.6个月期间,LSSM组12/274例(4.4%)和常规组11/274例(4.0%)发生静脉曲张出血(log-rank检验P=0.724)。
- 两组肝脏事件发生率相似(P=0.327)。
临床怎么用
- 肝硬化患者可首先进行LSSM测量以节省多达一半的上消化道内镜检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We previously demonstrated the possible noninferiority of a screening strategy for varices guided by liver and spleen stiffness measurement (LSSM) compared to universal endoscopic screening in detecting clinically significant varices in patients with cirrhosis. We now report the long-term outcome of the patients recruited in this trial for incident variceal bleeding and other hepatic events. This was a prospective follow-up study of a noninferiority, open-label, randomized controlled trial (NCT02024347) of 548 adult patients with known chronic liver diseases, radiological evidence of liver cirrhosis, and compensated liver function. The primary outcome of this prospective study was incident variceal bleeding confirmed with upper endoscopy. Between October 2013 and June 2016, 548 patients were randomized to an LSSM arm (n = 274) and a conventional arm (n = 274). Patients in both study arms were predominantly middle-aged men (mean age 59 years, male 68.9%) with viral hepatitis-related cirrhosis (85%). Upper endoscopy examination was performed in 127 (46.4%) patients in the LSSM arm and 263 (96.0%) in the conventional arm. During the follow-up period of 41.3 ± 12.6 months, 12/274 patients in the LSSM arm (4.4%) and 11/274 in the conventional arm (4.0%) developed incident variceal bleeding (log-rank test P = 0.724). The incident rates of hepatic events were also similar in both arms (P = 0.327). Conclusions: Patients with liver cirrhosis who had undergone LSSM-guided variceal screening were at similarly low risk of incident variceal bleeding in the future; patients with cirrhosis may first have LSSM measured to save up to half of the upper endoscopy examinations.
引用
- Wong GL, Liang LY, Kwok R, et al. Low Risk of Variceal Bleeding in Patients With Cirrhosis After Variceal Screening Stratified by Liver/Spleen Stiffness. Hepatology. 2019. PMID: 30681726. doi:10.1002/hep.30522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。